SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-241092
Filing Date
2024-10-22
Accepted
2024-10-22 16:35:00
Documents
15
Period of Report
2024-10-22
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d876702d8k.htm   iXBRL 8-K 26100
2 EX-99.1 d876702dex991.htm EX-99.1 15989
6 GRAPHIC g876702g1022211003854.jpg GRAPHIC 4037
  Complete submission text file 0001193125-24-241092.txt   179682

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA anro-20241022.xsd EX-101.SCH 2879
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE anro-20241022_lab.xml EX-101.LAB 18739
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE anro-20241022_pre.xml EX-101.PRE 11727
17 EXTRACTED XBRL INSTANCE DOCUMENT d876702d8k_htm.xml XML 3770
Mailing Address 650 CASTRO STREET, SUITE 450 MOUNTAIN VIEW CA 94041
Business Address 650 CASTRO STREET, SUITE 450 MOUNTAIN VIEW CA 94041 773-255-5012
Alto Neuroscience, Inc. (Filer) CIK: 0001999480 (see all company filings)

IRS No.: 834210124 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41944 | Film No.: 241386708
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)